Peter Mueller, EVP, Global R&D, CSO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 6,903 shares at $67.72 ($471K) on 2014-06-16, disclosed to the SEC on 2014-06-18.
Scheduled sale ($471k) by EVP, Global R&D, CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $67.72 | 4,403 | $298K | 63.3% |
| 2 | $68.25 | 1,500 | $102K | 21.7% |
| 3 | $70.29 | 1,000 | $70K | 14.9% |
| Total | $68.21 avg | 6,903 | $471K | 100% |
| Filing → |
| BTAI | BUY | 2018-12-07 | $44K | — | Filing → |
| BTAI | BUY | 2018-12-06 | $21K | — | Filing → |
| VRTX | SELL | 2014-05-16 | $506K | — | Filing → |